A Study to Evaluate the Efficacy and Safety of TTYP01 Tablets in Early Symptomatic Alzheimer's Disease
Clinical trial NCT07252440 · RECRUITING
Trial details
- NCT number
- NCT07252440
- Sponsor
- Shanghai Auzone Biological Technology Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-19
- Primary completion
- 2028-10-23
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.